PTCE Pharmacy Connect | Pharmacy Times

New and Emerging Non-Opioid Treatment Strategies for Pain Management: An Update for Pharmacists | PTCE Pharmacy Connect

Educational Objectives
Describe the impact of COVID-19 on surgical pain management 
Review current postoperative pain management guidelines and emerging non-opioid treatment approaches for pain management, including safety and efficacy data on newer treatments, and key considerations for pharmacists
Faculty:
Jawad N. Saleh, PharmD, BS, BCPS, BCCCP
Clinical Manager of Pharmacy Services
Pharmacy Department
The Hospital for Special Surgery
New York, New York
Faculty, has the following financial relationships with commercial interests to disclose:
Jawad N. Saleh, PharmD, BS, BCPS, BCCCP, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Heron Therapeutics, Baudax Bio
Speakers Bureau: Heron Therapeutics, Baudax Bio
Scientific Advisory Boards: Heron Therapeutics, Baudax Bio
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.075 CEU) under the ACPE universal activity number 0290-0000-22-046-H08-P. The activity is available for CE credit through February 24, 2023.
This activity is supported by an educational grant from Heron.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Promising Role of Microbiome-Based Drugs for the Treatment and Prevention of Recurrent Clostridioides Difficile | PTCE Pharmacy Connect

Educational Objectives
Discuss the role of disruptions in the gut microbiome in the development of Clostridioides difficile infection (CDI) and recurrent CDIs
Review the efficacy, safety, and role of fecal microbiota transplantation and emerging microbiome-based drugs for treatment of CDIs and rCDIs
Faculty:
Kevin W. Garey, PharmD, MS
Professor and Chair
University of Houston College of Pharmacy 
Houston, Texas
Kevin W. Garey, PharmD, MS, has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: Summit, Acurx, and Parakek Pharmaceuticals, and Seres Therapeutics
Consultant: Ferring Pharmaceuticals
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.075 CEU) under the ACPE universal activity number 0290-0000-22-048-H01-P. The activity is available for CE credit through January 31, 2023.
This activity is supported by a medical education grant from Ferring Pharmaceuticals.
Participants can claim credit for this CE activity by following the link below:
https://www.pharmacytimes.org/courses/the-promising-role-of-microbiome-based-drugs-for-the-treatment-and-prevention-of-recurrent-clostridioides-difficile
Learn more about your ad choices. Visit megaphone.fm/adchoices

Proactive Management of Adverse Effects Associated With Waldenström Macroglobulinemia | PTCE Pharmacy Connect

Educational Objective
Identify best practices for managing toxicities associated with therapies for the treatment of Waldenström macroglobulinemia
 
Faculty: Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist, Ambulatory Hematology Oncology
University of Michigan Rogel Cancer Center
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan
Faculty has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-21-457-H01-P. The activity is available for CE credit through June 20, 2022.
This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc; and BeiGene, Ltd.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Strategies for Pharmacist Involvement in Adverse Effect Management | PTCE Pharmacy Connect

Educational Objectives
·            Recognize best practices for managing adverse effects associated with immune checkpoint inhibitor (ICI)-targeted therapy combinations
 
Faculty:
Jacob K. Kettle, PharmD, BCOP
Pharmacy Manager
Ellis Fischel Cancer Center
Department of Pharmacy
University of Missouri Health Care
Columbia, Missouri
 
Faculty, has the following financial relationships with commercial interests to disclose:
Jacob Kettle, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Speakers Bureau: Genentech, Merck, Amgen, Lilly, DSI
Consultant: Pfizer, Lilly
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-21-438-H01-P. The activity is available for CE credit through December 17, 2022.
This activity is supported by educational grants from Eisai Inc and Exelixis, Inc.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Establishing the Role of Targeted Therapies in Cancer Care | PTCE Pharmacy Connect

Educational Objectives
·             Describe the role of immune checkpoint inhibitor (ICI)-targeted therapy combinations across malignancies
·             Recall knowledge of ICI-targeted therapy combinations to treatment selection in patients with cancer
 
Faculty:
Jacob K. Kettle, PharmD, BCOP
Pharmacy Manager
Ellis Fischel Cancer Center
Department of Pharmacy
University of Missouri Health Care
Columbia, Missouri
Faculty, has the following financial relationships with commercial interests to disclose:
Jacob Kettle, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Speakers Bureau: Genentech, Merck, Amgen, Lilly, DSI
Consultant: Pfizer, Lilly
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-437-H01-P. The activity is available for CE credit through December 17, 2022.
This activity is supported by educational grants from Eisai Inc and Exelixis, Inc.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Waldenström Macroglobulinemia and Treatment Advancements with the Use of BTK Inhibitors | PTCE Pharmacy Connect

Pharmacy Times Continuing Education™ (PTCE) provides industry-leading pharmacy CE to retail, oncology, managed care, specialty, and health-system pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Podcast 1: Waldenström Macroglobulinemia and Treatment Advancements with the Use of BTK Inhibitors
Educational Objectives
·             Outline the pathophysiology of Waldenström macroglobulinemia (WM) and its connection to use of new and emerging drug therapies
·             Review clinical guidelines and treatment selection in patients with WM
Faculty: Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist, Ambulatory Hematology Oncology
University of Michigan Rogel Cancer Center
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan
 
Faculty has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-21-441-H01-P. The activity is available for CE credit through June 13, 2022. 
This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc; and BeiGene, Ltd.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Optimizing Care for People Living with HIV: Beyond Typical Risk Factors for Weight Gain | PTCE Pharmacy Connect

Optimizing Care for People Living with HIV: Beyond Typical Risk Factors for Weight Gain | PTCE Connect Educational Objectives Describe recent data surrounding weight gain among people living with HIV (PLWH) who are on antiretroviral therapy Recognize the role of the pharmacist in the care of PLWH Continuing the Conversation – Individualizing the Management of HIV: A Focus on Weight Gain Introduction of faculty, affiliations, and disclosures Dr. David Koren, PharmD, MPH, BCPS, AAHIVP, Clinical Pharmacist Specialist in Infectious Diseases at the Temple University Health System, Philadelphia, Pennsylvania Dr. Koren has the following relevant financial relationships with commercial interests to disclose: Advisory Boards: Gilead, Thera, and ViiV Independent consulting: AbbVie and Thera Accreditation and support statement PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 credit hours of knowledge-based credit. This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP. Access PTCE here: https://www.pharmacytimes.org/on-demand/continuing-the-conversation-individualizing-the-management-of-hiv-a-focus-on-weight-gain See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Impact of COVID-19 Vaccine Hesitancy and Overcoming Patient Barriers | PTCE Connect

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Educational Objectives:
Discuss the various barriers to COVID-19 vaccine uptake including reasons for vaccine hesitancy
Review how pharmacists can address the reluctance of COVID-19 vaccination in communities
Faculty:
Rachel Armstrong, PsyD
Clinical Psychologist
Portsmouth, NH
Rachel Armstrong, PsyD, has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-283-H06-P. The activity is available for CE credit through July 29, 2022.
This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Adverse Effects versus Convenience of the COVID-19 Viral-Vector Vaccines | PTCE Connect

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Adverse Effects versus Convenience of the COVID-19 Viral-Vector Vaccines
Educational Objectives:
Articulate the benefits of viral-vector vaccines compared with the risk of thrombosis with thrombocytopenia syndrome (TTS)
Elaborate on current viral-vector TTS adverse effect incidence data and risk among patients who have received or will receive a viral-vector vaccine
 Faculty:
James Lewis, PharmD, FIDSA
ID Clinical Pharmacy Supervisor
Oregon Health & Sciences University
Portland, Oregon
James Lewis, PharmD, FIDSA, has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-264-H06-P. The activity is available for CE credit through June 29, 2022.
This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Implementing Digital Technology Tools within Health-Systems for Improving Adherence and Patient Support | PTCE Pharmacy Connect

Implementing Digital Technology Tools within Health-Systems for Improving Adherence and Patient Support
Educational Objectives:
At the completion of this activity, participants will be able to:
Define the pharmacist’s role in implementing digital and telemedicine technologies within the health system to improve adherence and provide remote patient monitoring and management.
Anthony J. Perissinotti, PharmD, BCOP is a Clinical Pharmacist Specialist, Hematology and the Clinical Team Leader Hematology/Oncology as well as an Adjunct Clinical Assistant Professor at the University of Michigan - Michigan Medicine in Ann Arbor, Michigan
He has no relevant financial relationships with commercial interests to disclose.
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours of knowledge-based credit.
Click here to view the activity on the PTCE website and claim your credit: https://www.pharmacytimes.org/on-demand/bcell-malignancies-podcast-part2
This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc and Beigene.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices